India a autorizat în premieră utilizarea unui vaccin împotriva febrei denga

India has approved the use of Qdenga, a dengue vaccine by Takeda, marking a significant step in public health. The vaccine is recommended for individuals aged 4 to 60 and is administered in two doses. Dengue fever poses a global health risk, with millions of infections annually. India has reported over 1 million cases since 2021, including at least 1,500 fatalities. The vaccine has already been authorized in around 40 countries, while another Indian company is conducting final trials for a single-dose vaccine.